These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 22638913)

  • 1. Ovarian cancer stem cells: elusive targets for chemotherapy.
    Guddati AK
    Med Oncol; 2012 Dec; 29(5):3400-8. PubMed ID: 22638913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ovarian cancer stem cells: Molecular concepts and relevance as therapeutic targets.
    Ahmed N; Abubaker K; Findlay JK
    Mol Aspects Med; 2014 Oct; 39():110-25. PubMed ID: 23811037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eliminating ovarian cancer stem cells: a potential therapeutic target for ovarian cancer chemoresistance.
    Wang X; Li X; Fu X; Bai M; Li X; Mei Q; Nie J; Wu Z; Han W
    Curr Protein Pept Sci; 2015; 16(4):270-8. PubMed ID: 25929861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of disease progression in ovarian cancer by utilizing 'chemograms' of ovarian cancer stem cells.
    Guddati AK; Shaheen S
    J Chemother; 2013 Jun; 25(3):184-91. PubMed ID: 23783145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New markers for human ovarian cancer that link platinum resistance to the cancer stem cell phenotype and define new therapeutic combinations and diagnostic tools.
    Muñoz-Galván S; Felipe-Abrio B; García-Carrasco M; Domínguez-Piñol J; Suarez-Martinez E; Verdugo-Sivianes EM; Espinosa-Sánchez A; Navas LE; Otero-Albiol D; Marin JJ; Jiménez-García MP; García-Heredia JM; Quiroga AG; Estevez-Garcia P; Carnero A
    J Exp Clin Cancer Res; 2019 Jun; 38(1):234. PubMed ID: 31159852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting Cancer Stem Cells to Overcome Therapy Resistance in Ovarian Cancer.
    Muñoz-Galván S; Carnero A
    Cells; 2020 Jun; 9(6):. PubMed ID: 32512891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rad6 upregulation promotes stem cell-like characteristics and platinum resistance in ovarian cancer.
    Somasagara RR; Tripathi K; Spencer SM; Clark DW; Barnett R; Bachaboina L; Scalici J; Rocconi RP; Piazza GA; Palle K
    Biochem Biophys Res Commun; 2016 Jan; 469(3):449-55. PubMed ID: 26679603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of MYPT1 increases tumor resistance in ovarian cancer by targeting the Hippo pathway and increasing the stemness.
    Muñoz-Galván S; Felipe-Abrio B; Verdugo-Sivianes EM; Perez M; Jiménez-García MP; Suarez-Martinez E; Estevez-Garcia P; Carnero A
    Mol Cancer; 2020 Jan; 19(1):7. PubMed ID: 31926547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic Strategies for Targeting Ovarian Cancer Stem Cells.
    Yang W; Kim D; Kim DK; Choi KU; Suh DS; Kim JH
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34064635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian cancer stem cell: A potential therapeutic target for overcoming multidrug resistance.
    Mihanfar A; Aghazadeh Attari J; Mohebbi I; Majidinia M; Kaviani M; Yousefi M; Yousefi B
    J Cell Physiol; 2019 Apr; 234(4):3238-3253. PubMed ID: 30317560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crucial role of HMGA1 in the self-renewal and drug resistance of ovarian cancer stem cells.
    Kim DK; Seo EJ; Choi EJ; Lee SI; Kwon YW; Jang IH; Kim SC; Kim KH; Suh DS; Seong-Jang K; Lee SC; Kim JH
    Exp Mol Med; 2016 Aug; 48(8):e255. PubMed ID: 27561949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancerous ovarian stem cells: obscure targets for therapy but relevant to chemoresistance.
    Ahmed N; Abubaker K; Findlay J; Quinn M
    J Cell Biochem; 2013 Jan; 114(1):21-34. PubMed ID: 22887554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical role of Wnt/β-catenin signaling in driving epithelial ovarian cancer platinum resistance.
    Nagaraj AB; Joseph P; Kovalenko O; Singh S; Armstrong A; Redline R; Resnick K; Zanotti K; Waggoner S; DiFeo A
    Oncotarget; 2015 Sep; 6(27):23720-34. PubMed ID: 26125441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A rational approach for cancer stem-like cell isolation and characterization using CD44 and prominin-1(CD133) as selection markers.
    Lee YJ; Wu CC; Li JW; Ou CC; Hsu SC; Tseng HH; Kao MC; Liu JY
    Oncotarget; 2016 Nov; 7(48):78499-78515. PubMed ID: 27655682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ALDH1A1-related stemness in high-grade serous ovarian cancer is a negative prognostic indicator but potentially targetable by EGFR/mTOR-PI3K/aurora kinase inhibitors.
    Kaipio K; Chen P; Roering P; Huhtinen K; Mikkonen P; Östling P; Lehtinen L; Mansuri N; Korpela T; Potdar S; Hynninen J; Auranen A; Grénman S; Wennerberg K; Hautaniemi S; Carpén O
    J Pathol; 2020 Feb; 250(2):159-169. PubMed ID: 31595974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanoparticle Delivery of TWIST Small Interfering RNA and Anticancer Drugs: A Therapeutic Approach for Combating Cancer.
    Glackin CA
    Enzymes; 2018; 44():83-101. PubMed ID: 30360816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic and Prognostic Biomarkers in ovarian cancer and the potential roles of cancer stem cells - An updated review.
    Muinao T; Deka Boruah HP; Pal M
    Exp Cell Res; 2018 Jan; 362(1):1-10. PubMed ID: 29079264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin against cancer stem cells through the modulation of energy metabolism: special considerations on ovarian cancer.
    Kim TH; Suh DH; Kim MK; Song YS
    Biomed Res Int; 2014; 2014():132702. PubMed ID: 25050322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovarian cancer stem cells: What progress have we made?
    Al-Alem LF; Pandya UM; Baker AT; Bellio C; Zarrella BD; Clark J; DiGloria CM; Rueda BR
    Int J Biochem Cell Biol; 2019 Feb; 107():92-103. PubMed ID: 30572025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting ovarian cancer-initiating cells.
    Murphy SK
    Anticancer Agents Med Chem; 2010 Feb; 10(2):157-63. PubMed ID: 20184540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.